Cancer Pill Approved For Treatment of Intestinal Tumors
The U.S. Food and Drug Administration has approved a new cancer pill, Stivarga, from the drug manufacturer Bayer HealthCare. This particular prescription pill will be used in the treatment of gastrointestinal stromal tumors that cannot be surgically removed and won’t respond FDA-approved cancer drugs and treatments. Stivarga had already been approved in the treatment of […]
1 min read